RELAPSE DIFFUSE LARGE B CELL LYMPHOMA

Clinical trials for RELAPSE DIFFUSE LARGE B CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RELAPSE DIFFUSE LARGE B CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for RELAPSE DIFFUSE LARGE B CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for patients Who've run out of options: experimental drug enters human testing

Disease control Ongoing

This early-stage study is testing a new oral drug called BGB-21447 in adults with certain advanced blood cancers that have returned or stopped responding to other treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also loo…

Matched conditions: RELAPSE DIFFUSE LARGE B CELL LYMPHOMA

Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control

Last updated Mar 12, 2026 13:51 UTC

RELAPSE DIFFUSE LARGE B CELL LYMPHOMA

Get alerted when new RELAPSE DIFFUSE LARGE B CELL LYMPHOMA trials appear

New hope for patients Who've run out of options: experimental drug enters human testing